RARECast

A podcast by RARECast - Thursdays

Thursdays

Categories:

512 Episodes

  1. aTyr Pharma Seeks to Modulate Activity in FSHD and Other Rare Disease

    Published: 6/28/2017
  2. Summit Pursues A Different Approach to Treating Duchenne

    Published: 6/21/2017
  3. Delivering Enzyme Replacement Therapies Across the Blood-Brain Barrier

    Published: 6/14/2017
  4. Sangamo Advances Gene Editing Therapies for Multiple Rare Diseases into the Clinic

    Published: 6/7/2017
  5. Navigating the Challenges of Rare Disease Drug Development

    Published: 5/31/2017
  6. Accelerating Rare Disease Drug Discovery

    Published: 5/24/2017
  7. Experimental Rare Disease Therapy Wins New FDA Reg Med Designation

    Published: 5/17/2017
  8. How Rare Disease Patients Can Get their Voices Heard in Drug Discovery and Development

    Published: 5/10/2017
  9. One Patient's Difficult Road to a Rare Diagnosis

    Published: 5/3/2017
  10. How Researchers Diagnosed Four Patients with a Never-Before-Identified Rare Disease in a Day

    Published: 4/26/2017
  11. Stem Cell Gene Therapy Restores Immune System in Kids with SCID

    Published: 4/19/2017
  12. Rare Disease Advocates Push for Incentives to Drugmakers Pulled from Cures Act

    Published: 4/12/2017
  13. Non-Profit Drug Company Seeks to Advance Rare Disease Therapies

    Published: 4/5/2017
  14. Innovative Collaboration Model Drives Treatment for Rare Disease

    Published: 3/29/2017
  15. Girl with Rare Disease Inspires Search for Bone Marrow Donors

    Published: 3/22/2017
  16. A Quest for Tribe: Searching for Others with the Same Ultra-Rare Mutation

    Published: 3/15/2017
  17. Raising Awareness in a Town with a History of a Rare Disease

    Published: 3/8/2017
  18. Helping Rare Disease Patients Navigate the World of Information

    Published: 3/1/2017
  19. Overcoming the Challenges of Rare Disease Drug Development

    Published: 2/22/2017
  20. Moving Rare Disease Therapies from Hope to Reality

    Published: 2/15/2017

20 / 26

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.